U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H21B2NO5
Molecular Weight 377.006
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of AM-114

SMILES

CN1C\C(=C\C2=CC=C(C=C2)B(O)O)C(=O)\C(C1)=C/C3=CC=C(C=C3)B(O)O

InChI

InChIKey=SRPIKXGUPAKTIZ-APGQMXJTSA-N
InChI=1S/C20H21B2NO5/c1-23-12-16(10-14-2-6-18(7-3-14)21(25)26)20(24)17(13-23)11-15-4-8-19(9-5-15)22(27)28/h2-11,25-28H,12-13H2,1H3/b16-10-,17-11-

HIDE SMILES / InChI

Molecular Formula C20H21B2NO5
Molecular Weight 377.006
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 2
Optical Activity NONE

AM-114, a derivative of boronic chalcone, is a potent small-molecule inhibitor of the proteasome that inhibits the chymotrypsin-like activity of the 20S proteasome, with a value of 50% inhibition concentration IC50 of approximately 1 uM, resulting in a significant accumulation of ubiquitinated p53 and other cellular proteins in whole cells without significantly disrupting the interaction of p53 and murine double minute 2 (mdm2) proteins. AM 114 also exerts anti-cancer activity against cancer cells, which potently inhibits the growth of human colon cancer HCT116 cells with values of IC50 of 1.5 uM and 0.6 uM in MTT and colony formation assays respectively.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: CHEMBL3831201: 20S proteasome
1.0 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Patents

Patents

Sample Use Guides

Following oral dosing, AM-114 gave detectable serum levels, indicating approximately 30% bioavailability.
Route of Administration: Oral
1 uM AM-114 caused a loss of cell survival in the HCT116 p53+/+ and p53-/- cells by approximately 70 and 20%,respectively. AM-114 exhibited potent activity against p53+/+ cells in colony formation assay, with an IC50 value of 0.6 uM. 1 uM AM-114 inhibited 20S proteasome activity by 46%, and 3 uM AM-114 inhibited proteasome activity by 76%.
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:36:19 GMT 2023
Edited
by admin
on Sat Dec 16 08:36:19 GMT 2023
Record UNII
4H5Y396039
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AM-114
Common Name English
BORONIC ACID, ((1-METHYL-4-OXO-3,5-PIPERIDINEDIYLIDENE)BIS(METHYLIDYNE-4,1-PHENYLENE))BIS-
Systematic Name English
BORONIC ACID, B,B'-((1-METHYL-4-OXO-3,5-PIPERIDINEDIYLIDENE)BIS(METHYLIDYNE-4,1-PHENYLENE))BIS-
Systematic Name English
Code System Code Type Description
CAS
856849-35-9
Created by admin on Sat Dec 16 08:36:19 GMT 2023 , Edited by admin on Sat Dec 16 08:36:19 GMT 2023
PRIMARY
FDA UNII
4H5Y396039
Created by admin on Sat Dec 16 08:36:19 GMT 2023 , Edited by admin on Sat Dec 16 08:36:19 GMT 2023
PRIMARY
PUBCHEM
72941923
Created by admin on Sat Dec 16 08:36:19 GMT 2023 , Edited by admin on Sat Dec 16 08:36:19 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY